ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

CaMKII-based gene therapy protects retinal ganglion cells in a broad range of disease: ischemic retinopathy and congenital glaucoma.

Jing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.